Are chemical compounds in medical mushrooms potent against colorectal cancer carcinogenesis and antimicrobial growth?
John M MachariaLu ZhangRuth W MwangiNora RozmannZsolt KaposztasTímea VarjasMiklós SugárHuda AlfataftaMárton PintérRaposa L BencePublished in: Cancer cell international (2022)
After cardiovascular diseases, cancer is the second main cause of death globally. Mushrooms have been demonstrated to contain amalgamation with properties capable of inhibiting carcinogenesis and microbial growth, principally secondary metabolites such as quinolones, steroids, terpenes, anthraquinones, and benzoic acid derivatives among others. This study aimed to substantiate their potency concerning colon cancer carcinogenesis and antimicrobial growth. A systematic search of important literature was performed considering all the articles published until April 2022. Screening was performed by searching the BMC Springer, Elsevier, Embase, Web of Science, Ovid, and MEDLINE databases. In addition, Google Scholar was used to supplement information. Titles and abstracts that matched the established criteria were selected for full-text article scrutiny and subsequently used in the updated present review. Bioactive compounds present in medicinal mushrooms such as ascorbic acid, organic acids, flavonoids, polysaccharides, glycosides, phenols, linoleic acid, grifolin, and tocopherols among other compounds play a key role in suppressing the proliferation of cancerous cells and selectively act as antibacterial and antifungal agents. These metabolites actively scavenge oxygen free radicals, hydroxyl radicals, and nitrite radicals that would otherwise increase the risks of the growth and development of cancerous cells. Mushrooms' bioactive compounds and metabolites actively inhibit nuclear factor-kappa activation, protein kinase B processes, and ultimately the expression of Cyclooxygenases 2 in cancerous cells. Medicinal mushrooms should be considered as alternative natural chemo-preventive agents in the global fight against colon cancer and the evolution of drug-resistant pathogenic microorganisms, as they exhibit robust potency. They have not been reported to exhibit adverse harmful effects compared to synthetic chemotherapies, yet they have been reported to demonstrate significant beneficial effects.
Keyphrases
- induced apoptosis
- drug resistant
- nuclear factor
- cell cycle arrest
- signaling pathway
- staphylococcus aureus
- multidrug resistant
- healthcare
- endoplasmic reticulum stress
- toll like receptor
- public health
- oxidative stress
- social media
- microbial community
- cell death
- randomized controlled trial
- acinetobacter baumannii
- anti inflammatory
- risk assessment
- cell proliferation
- cancer therapy
- deep learning
- artificial intelligence
- cardiovascular events
- health information
- smoking cessation
- lymph node metastasis
- wound healing